
ABOUT ANJU SOFTWARE
Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients’ lives. Anju is a portfolio company of Abry Partners serving the worldwide pharmaceutical, biotech, and contract research life sciences markets.
ECLINICAL
-
As EDC systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.
-
The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.
-
Discover how maintaining strong data integrity can transform your clinical trials and strategies you can use to optimize trial builds and streamline data collection processes, ultimately leading to faster approvals.
-
How can Electronic Data Capture (EDC) tools streamline your data collection process and help you manage the increasing complexity and data?
-
Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.
-
Integrated digital solutions are helping clinical trial managers address significant operational challenges that raise costs and prolong trial durations.
-
Navigating the intricacies of clinical trials demands adept handling of document management, regulatory compliance, and financial forecasting. Learn key strategies for overcoming these hurdles.
-
Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.
CONTACT INFORMATION
Anju Software
4500 S Lakeshore Drive
Tempe, AZ 85282
UNITED STATES
MEDICAL AFFAIRS
-
Delve into strategies for effectively monitoring and reporting progress toward achieving patient diversity objectives.
-
Online medical misinformation abounds, and pharmaceutical companies need dedicated MA resources to communicate with HCPs and consumers to ensure the material they find is up-to-date and accurate.
-
Drug development is slow and costly. Learn how a state-of-the-art system can increase efficiency and ROI by providing valuable data insights and superior customer service.
-
Learn why it’s important to build strong relationships with opinion leaders in the healthcare industry, as well as how to establish and maintain them.
-
Engaging with digital opinion leaders is essential to growing brand recognition and moving products forward. Follow these five tips to better connect with experts online.
DATA SCIENCE
-
Discover how TA Scan’s Trial Feasibility Flex transforms feasibility planning from reactive to proactive—accelerating timelines and reducing risk.
-
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Engaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.
-
Discover a trial feasibility tool that integrates users' operational insights with high-quality clinical intelligence to drive accurate and informed enrollment projections and site capacity analyses.
-
Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.